Holen Sie sich die Stockscreener-App
6.85
2.50%
0.25
Schlusskurs vom Vortag:
$6.60
Offen:
$6.73
24-Stunden-Volumen:
2,687
Relative Volume:
0.08
Marktkapitalisierung:
$56.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.34%
1M Leistung:
-7.71%
6M Leistung:
+29.89%
1J Leistung:
+6.03%
1-Tages-Spanne:
$6.675
$6.85
1-Wochen-Bereich:
$6.60
$6.99
52-Wochen-Spanne:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Firmenname
Neuehealth Inc
Sektor
Branche
Telefon
612-238-1321
Adresse
9250 NW 36TH STREET, DORAL
Vergleichen Sie NEUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.85 | 56.91M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
522.85 | 479.14B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
429.14 | 97.95B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
331.03 | 89.74B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.95 | 85.71B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
263.70 | 31.95B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Eingeleitet | Goldman | Buy |
| 2021-07-19 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Neuehealth Inc Aktie (NEUE) Neueste Nachrichten
Virtu Financial LLC Takes Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript - MSN
NeueHealth Inc. Earnings Call Highlights Growth and Acquisition - TipRanks
NeueHealth Inc. (NEUE) reports earnings - Quartz
NeueHealth: Q4 Earnings Snapshot - Midland Daily News
NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong 2024 Financial Performance - TipRanks
NeueHealth Inc reports results for the quarter ended December 31Earnings Summary - TradingView
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - Nasdaq
NEUEHEALTH Earnings Results: $NEUE Reports Quarterly Earnings - Nasdaq
NeueHealth Reports Fourth Quarter and Full Year 2024 Results - TradingView
NeueHealth Crushes Growth Targets: Consumer Base Surges 48% as 2024 Hits All-Time Highs - Stock Titan
NeueHealth reaches modified repayment agreement with CMS By Investing.com - Investing.com Australia
NeueHealth reaches modified repayment agreement with CMS - Investing.com India
NeueHealth IncOn March 13, Insurance Units Modify Repayment Agreements With CMSSEC Filing - Marketscreener.com
NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February - Defense World
NeueHealth Executives Sell Shares Worth Over $411K - TradingView
neuehealth EVP Tomas Orozco sells $13,235 in stock By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan sells $117,004 in stock By Investing.com - Investing.com Australia
Neuehealth’s chief accounting officer sells $5,523 in stock transactions By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock - Investing.com India
Neuehealth’s chief accounting officer sells $5,523 in stock transactions - Investing.com India
neuehealth EVP Tomas Orozco sells $13,235 in stock - Investing.com India
neuehealth gc Craig Jeffery Michael sells $7,940 in stock - Investing.com
neuehealth gc Craig Jeffery Michael sells $7,940 in stock By Investing.com - Investing.com UK
NeueHealth CEO George Mikan sells $117,004 in stock - Investing.com
NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday - Defense World
NeueHealth CEO George Mikan III sells $203,009 in stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan III sells $203,009 in stock - Investing.com India
NeueHealth EVP Tomas Orozco sells $4,599 in stock By Investing.com - Investing.com South Africa
NeueHealth GC Craig Michael sells $8,929 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock - Investing.com India
NeueHealth GC Craig Michael sells $8,929 in stock - Investing.com India
Neuehealth CFO Matushak sells $14,672 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock By Investing.com - Investing.com South Africa
NeueHealth Executives Sell Shares - TradingView
Neuehealth CFO Matushak sells $14,672 in stock - Investing.com
NeueHealth EVP Tomas Orozco sells $4,599 in stock - Investing.com
NeueHealth (NEUE) Projected to Post Earnings on Wednesday - Defense World
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025 - The Bakersfield Californian
When Will NeueHealth Reveal Its Q4 Performance? Key Date for Investors - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBRDA, AMPS, NEUE on Behalf of Shareholders - Marketscreener.com
Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions - Lexology
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of Shareholders - Marketscreener.com
Finanzdaten der Neuehealth Inc-Aktie (NEUE)
Es liegen keine Finanzdaten für Neuehealth Inc (NEUE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
2.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):